National Research Corporation Operating Income 2011-2026 | NRC

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income National Research Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
22.6 M	35.2 M	40 M	46.5 M	50.3 M	42.7 M	43 M	35.3 M	34.2 M	31.2 M	26.4 M	28.3 M	24.8 M	22.7 M	18.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.3 M	18.7 M	33.5 M

Quarterly Operating Income National Research Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
7.74 M	1.59 M	8.6 M	-	7.98 M	8.86 M	8.76 M	-	9.96 M	9.36 M	9.02 M	-	11.1 M	11.5 M	11.7 M	-	13.1 M	12.2 M	12 M	-	12 M	9.28 M	11.2 M	-	10.2 M	10.1 M	10.7 M	-	9.17 M	7.76 M	8.96 M	-	7.12 M	8.45 M	9.98 M	-	7.34 M	7.02 M	8.01 M	-	6.55 M	6.36 M	5.83 M	-	7.16 M	6.32 M	8.4 M	-	6.03 M	5.53 M	7.22 M	-	5.65 M	5.22 M	6.08 M	-	4.19 M	3.83 M	5.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.1 M	1.59 M	8.24 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Koninklijke Philips N.V. PHG	553 M	$ 29.7	3.74 %	$ 20 B	Niderland
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.35 B	$ 121.87	3.06 %	$ 37 B	USA
Burning Rock Biotech Limited BNR	-797 M	$ 20.67	-8.13 %	$ 222 M	China
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	-7.91 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-25.9 M	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
CareDx, Inc CDNA	-30.8 M	$ 21.42	-4.46 %	$ 1.14 B	USA
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-50.2 M	$ 1.56	6.85 %	$ 2.08 M	USA
Exact Sciences Corporation EXAS	-206 M	-	-	$ 19.8 B	USA
Castle Biosciences CSTL	8.67 M	$ 25.05	2.0 %	$ 696 M	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	25.2 M	$ 183.88	3.92 %	$ 9.11 B	USA
Danaher Corporation DHR	4.69 B	$ 194.75	0.5 %	$ 139 B	USA
Interpace Biosciences IDXG	4.08 M	$ 2.0	-9.09 %	$ 8.85 M	USA
Myriad Genetics MYGN	-387 M	$ 5.08	1.6 %	$ 470 M	USA
Heska Corporation HSKA	-20.3 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-20.8 M	-	-20.0 %	$ 1.06 M	USA
NeoGenomics NEO	-116 M	$ 8.35	2.33 %	$ 1.07 B	USA
Neogen Corporation NEOG	-1.06 B	$ 9.51	2.92 %	$ 2.06 B	USA
Medpace Holdings MEDP	535 M	$ 520.6	0.96 %	$ 15 B	USA
Illumina ILMN	-833 M	$ 134.5	1.34 %	$ 21.4 B	USA
Precipio PRPO	-1.2 M	$ 28.3	-2.41 %	$ 45.4 M	USA
Fulgent Genetics FLGT	-73.9 M	$ 16.26	0.81 %	$ 492 M	USA
Guardant Health GH	-437 M	$ 90.36	5.44 %	$ 11.3 B	USA
Senseonics Holdings SENS	-68.3 M	$ 6.77	-	$ 282 M	USA
QIAGEN N.V. QGEN	466 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-11.7 M	$ 2.91	2.83 %	$ 94.4 K	USA
Soleno Therapeutics SLNO	9.41 M	$ 52.78	0.4 %	$ 2.68 B	USA
Biomerica BMRA	-5.14 M	$ 2.18	-0.91 %	$ 5.01 M	USA
Motus GI Holdings MOTS	-11.9 M	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	1.1 B	$ 119.68	3.55 %	$ 9.87 B	Irlanda
Laboratory Corporation of America Holdings LH	1.38 B	$ 270.68	1.62 %	$ 22.5 B	USA
Neuronetics STIM	-31.4 M	$ 1.42	1.43 %	$ 93.7 M	USA
Celcuity CELC	-172 M	$ 122.46	-2.23 %	$ 5.73 B	USA
Lantheus Holdings LNTH	311 M	$ 83.82	-0.12 %	$ 5.66 B	USA
Thermo Fisher Scientific TMO	7.75 B	$ 526.6	2.05 %	$ 199 B	USA
Trinity Biotech plc TRIB	6.62 M	$ 0.75	6.62 %	$ 61.9 M	Irlanda
Quest Diagnostics Incorporated DGX	1.56 B	$ 195.02	1.86 %	$ 21.6 B	USA
ENDRA Life Sciences NDRA	-5.76 M	$ 6.4	23.79 %	$ 5.04 M	USA